ArticleCrohn's & colitis 3602023

Correction to: Practical Primer Addressing Real-World Use Scenarios of Subcutaneous Vedolizumab in Ulcerative Colitis and Crohn's Disease: Post Hoc Analyses of VISIBLE Studies.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.